Seattle Cancer Care Alliance offers comprehensive consultations and treatments for aplastic anemia and other blood disorders.
SCCA was formed, in part, to bring promising new treatments to patients faster. This means that people who have been diagnosed with aplastic anemia will find more treatment options at SCCA than might be found elsewhere, including one of many clinical studies being conducted at SCCA and its parent organizations, Fred Hutch and UW Medicine.
If your condition requires a bone marrow transplant, you should know that the Fred Hutch Transplant program at SCCA was ranked first in outcomes in a four-year study by the National Marrow Donor Program (NMDP) that measured one-year survival rates of patients among 122 transplant centers in the United States. The Hutch pioneered the use of bone marrow transplants as a treatment for blood diseases over 40 years ago. Since many patients with aplastic anemia have come from around the world to receive bone marrow transplants at SCCA.
In June 2010, the Hutch held a one-day conference for aplastic anemia patients and their families. Speakers included several SCCA doctors who addressed wide range of topics including the diagnosis and treatment of blood diseases such as aplastic anemia. Click here to view the video transcripts from the conference.